Nordic Nanovector ASA (8NN) Financial Statements
Nordic Nanovector ASA Financial Overview
Nordic Nanovector ASA's market cap is currently $164.39M. The company's EPS TTM is $-0.23; its P/E ratio is -17.46; Nordic Nanovector ASA is scheduled to report earnings on November 10, 2022, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 400.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 400.00K | $ -2.38M | $ -331.00K | $ 0.00 | $ -11.37M |
| Operating Income | $ -69.70M | $ -52.71M | $ -7.34M | $ 0.00 | $ -442.43M |
| EBITDA | $ -48.80M | $ -50.33M | $ -7.01M | $ 11.20M | $ -428.35M |
| Net Income | $ -58.00M | $ -42.21M | $ -26.56M | $ -311.24M | $ -441.30M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 180.60M | $ 123.40M | $ 41.28M | $ 96.55M | $ 276.71M |
| Total Assets | $ 708.60M | $ 414.40M | $ 330.83M | $ 109.64M | $ 296.67M |
| Total Debt | $ 330.60M | $ 737.00K | $ 0.00 | $ 159.00K | $ 5.51M |
| Net Debt | $ 150.00M | $ -122.66M | $ -41.28M | $ -96.39M | $ -271.20M |
| Total Liabilities | $ 252.70M | $ 77.30M | $ 58.91M | $ 45.80M | $ 156.16M |
| Stockholders' Equity | $ 456.00M | $ 337.10M | $ 271.93M | $ 63.84M | $ 140.52M |
| Cash Flow | |||||
| Free Cash Flow | $ -114.60M | $ -23.80M | $ -64.09M | $ -414.71M | $ -403.72M |
| Operating Cash Flow | $ -41.50M | $ -23.70M | $ -64.09M | $ -409.08M | $ -403.46M |
| Investing Cash Flow | $ -73.10M | $ 1.30M | $ 6.28M | $ -2.46M | $ 863.00K |
| Financing Cash Flow | $ 171.80M | $ 104.00M | $ -332.00K | $ 228.13M | $ 385.10M |
Currency in NOK